In a recent Benefits Pro article What employers need to know about "guided use" of cannabis by Dr. Brooke Worster, an Associate Professor of Medicine at Jefferson Health in Philadelphia, PA, the Director of the Division of Supportive Oncology, and the Program Director of Cannabis Medicine for the Science and Business Master’s Program, she explores the evolving dynamics of employee cannabis use, as well as implications, and opportunities to provide guidance on when, where, and what cannabis use is acceptable.Â
In a rapidly changing landscape where cannabis is now legal in most states, the need for informed guidance for employers and employees is paramount. The role of employers in ensuring safe, guided cannabis use is becoming increasingly important.Â
Medical experts advocate for the potential benefits of cannabis in treating various medical conditions. Boasting a massive $33 billion in sales, $10 billion of which is directed towards health-related usage, cannabis is proving its place in modern health practices. As Gen Z and Millennials embrace this trend, employers face a crucial crossroads about providing guidance on safe cannabis consumption which remains largely uncharted territory in a landscape where clinical guidance is often lacking. More than ever, employers need to adapt their policies to support employees who may choose cannabis as part of their healthcare journey.Â
‍
Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,
As more states legalize the use of cannabis, it can be challenging for employers to keep up and find reliable information. A recent Benefits Pro article, Employees are more likely to apply for jobs that offer cannabis benefits, shares findings from an EO Care ...
1 in 2 people will get cancer in their lifetime, and 40% of cancer patients use cannabis for treatment of symptoms. But clinical guidance for cannabis is difficult to find. That’s why Imerman Angels is partnering with EO Care — the first clinically guided cannabis health and wellness solution for employers, payers, and associations — to provide cannabis care and advice to members. ImermanAngels.org visitors will be able to access educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.
Get special offers, event invites and the latest on new care offerings and product releases.
